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In this paper, we present a longitudinal study on me-
talloproteinases in wound-fluid samples collected 
from three patients with partial- to fnll-thickness burn 
wounds. Gelatin zymography showed that 92-kDa gel-
atinase (MMP-9) and its 225-kDa complex could be 
detected in burn fluid beginning as early as 4 - 8 h after 
injnry. Marked increases in MMP-9 levels as well as 
activation of the proenzyme occurred between day 0 
and day 2. The 72-kDa gelatinase (MMP-2) proenzyme 
was not detected until day 2 and activated enzyme did 
not appear until day 4. Stromelysin (MMP-3), both 
I dentifying the components of the wound environment has . become a major goal of wound-healing research. One ap-proach to studying the human wound environment has been through analysis of wound fluid. In general, wound fluid appears to be a transudate of blood containing plasma pro-
teins including the adhesion molecules fibronectin and vitronectin 
[1 - 3] . Wound-fluid samples from chronic wounds were found to 
contain degraded adhesion proteins [2,3], indicating that the wound 
environment might contain active proteinases. Subsequent analyses 
showed that high levels of72-kDa and 92-kDa gelatinases (MMP-2 
and MMP-9) were present in chronic wound fluid but not in surgi-
cal wound fluid [4]. Elevated levels of metalloproteinases also have 
been detected in burn-wound fluid [5]. and in burn fluid with ex-
tensively degraded fibronectin neutrophil elastase was tentatively 
identified as the enzyme responsible for degradation [6]. 
Gelatinases and other proteinases have been implicated in numer-
ous aspects of normal tissue repair and remodeling [7 -10], but the 
persistent presence of activated proteinases resulting in degradation 
of adhesion molecules and growth factors may contribute to failed 
healing of chronic wounds [11]. Similarly, abnormal proteinase ac-
tivity may playa role in the blistering diseases [12,13]. 
Our previous studies were limited to single wound-fluid samples 
from different patients. Without sequential samples from the same 
patients, we could not determine if differences in wound-fluid pro-
teinases profiles were unique to a particular wound or to the time at 
which fluid from the wound was sampled. Recently, however, we 
were abl e to obtain longitudinal samples over a 1 - 2-week period 
from each of three patients with burn injuries. For all three patients 
Manuscript received April 7, 1994; revised June 14, 1994; accepted for 
publication June 20, 1994. . 
Reprint requests to: Frederick Grinnell, Department of Cell Biology and 
Neuroscience, UT Southwestern Medical School, Dallas, TX 75235. 
Abbreviations: AEBSF, aminoethylbenzenesulfonylfluoride; MMP-1, in-
terstitial collagenase; MMP-2, 72-kDa gclatinase; MMP-3, stromclysin; 
MMP-9, 92-kDa gelatinase. 
proenzyme and activated-enzyme forms, was first ob-
served on day 4. Fluid-phase proteinase activity de-
tected by azocoll degradation roughly corresponded 
with the level of stromelysin rather than the gelatin-
ases. Our results provide evidence for a regulated me-
talloproteinase activation cascade following acute 
traumatic injury and demonstrate in vivo expression of 
metalloproteinase activity. Key words: woutld "ealitlg/ 
itljlammatiotl/ gelatinase/ stromelysin. ] Invest Dermatol 
103 :660 - 664, 1994 
we observed a similar metalloproteinase activation cascade that oc-
curred during the first 4 d after burn il~ury. Details are reported 
herein. 
MATERIALS AND METHODS 
Wound Fluid and Blood Samples This research project was approved 
by the University Institutional Review Board. Informed consent was ob-
tained for all procedures. The patients (summarized in Table I) had burn 
wounds that included an extremity. The diagnosis was partial-thickness 
burn injury for patients 5-1 and 5-2 and deep partial- to full-thickness burn 
injury for patient 5-4. Within several days, patient 5-2 began epithelial 
budding and was discharged from the hospital on day 13 without surgical 
intervention. Patients 5-1 and 5-4 did not show epithelial budding, and both 
were treated by split-thickness autografting on day 8. 
At the time of admission, prior to blister debridement, fluid from burn 
blisters on patient extremjties was collected using a steri le tuberculin syringe 
and 20-gauge needle. Sampling of burn fluid was initiated 4-8 h after injury 
(day 0) and continued at 48- to 72-h intervals unti l day 8 for patient 5-1, until 
day 13 for patient 5-2, and unti l day 6 for patient 5-4. Collections were 
carried out over 4-h periods, during which time patient extremities were 
enclosed in a sterile glove and held in place with a noncompressive cling 
wrap [5,6] . Blood samples were obtained from the patients by venipuncture. 
Collection of mastectomy fl uid, centrifugation and storage of wound-fluid 
samples, and preparation of plasma from blood were accomplished as de-
scribed previously [4-6] . Protein concentrations of the samples were deter-
mined by the Lowry method [14]. 
SDS-PAGE and Immunoblotting Samples of wound fluid or plasma 
were dissolved in reducing sample buffer (62.5 mM Tris, 1 % sodium dode-
cylsulfate, 10% glycerol, 0.01 % bromophenol blue, pH 6.8, 5% mercap-
toethanol), heated at 100°C for 3 min, and subjected to SDS-PAGE [15] on 
7.5% acrylamide mini-gels (BioRad Mini-Protean apparatus) at 22°C and 
120 V until the tracking dye reached the bottom of the gel (usually - 1 h) . 
Polypeptides were transferred to n.itrocellulose paper (Schleicher & Schuell) 
by electrophoresis at 22°C for 1 h at 100 V (BioRad Minitransblot Cell). 
Blots were incubated with blocking solution containing 5% Carnation low-
fat milk in 20 mM Tris, 150 111M NAcl, pH 7.5, for 40 min at 22°C, 
followed by a 16-h incubation with antibodies. After incubation with pri-
mary antibodies, samples were washed with blocking solution and then 
incubated with alkaline phosphatase-conjugated goat anti-mouse antibod-
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Table I. Patient Profile 
Patient Burn Size (%TBSA)' 
Number Race Gender Age (years) Total Hand/ Arm 
Burn Fluid 
Sampling Period 
5-1 
5-2 
5-4 
Caucasian 
Hispanic 
Caucasian 
, %TBSA, pcrccnt total body surfacc arca. 
F 
M 
M 
47 
56 
42 
ies (Bio-Rad, Richmond, CAl in blocking solution for 1-4 h at 22°C. 
Visualization was accomplished using an alkaline phosphatase-coruugate 
substrate kit (BioRad) according to the manufacturer's instructions. Mouse 
anti-proMMP-9 (7-11 C) and anti-MMP-9 (6-6B) [16] were provided by Dr. 
Debby French (SUNY Stony Brook), and mouse anti-MMP-3 and proen-
zyme and activated MMP-3 standards were provided by Dr. Scott Wilhelm 
(Miles Inc., West Haven, CT). 
Zymography Gelatinases were identified by zymography [17] using 
7.5% acry lamide gels containing 0.5% gelatin (bloom 225, Sigma Chemical 
Co.) as described previously [4 -6]. Areas of proteinase activity appeared as 
clear zones against a dark blue background. This method detects metallopro-
teinases even if they arc still in the proenzyme form. Photographic negatives 
of zymograms were analyzed using a Molecular Dynamics Densitometer 
(Sunnyvale, CAl. Band sizes arc shown in arbitrary units and were deter-
mined using the "volume integration" mode according to the manufac-
turer's instructions. 
Analysis of Proteinase Activity Using Azocoll Fluid-phase proteinase 
activity was analyzed using the azocoll method, which detects a variety of 
enzymes including metalloproteinases and serine proteinases [18]. Azocoll 
was washed and suspended in 0.05 M Tris-HCl, 1 mM CaCl2 , pH 7.8, at a 
final concentration of 5 mg/ml. Samples of burn fluid (0.4 mg) were mixed 
with 0.45 ml of azoco ll suspension and incubated for 21 h at 37"C with 
continuous shaking. The incubations were stopped by centrifuging the sam-
ples at 13,500 rpm (Beckman Microfuge II) for 8 min at 4 ° C. 00520 of the 
supernatants was measured with a Beckman DU-40 spectrophotometer. 
RESULTS 
General Burn Fluid Composition Figure 1 shows for patients 
5-1 and 5-2 the amounts of fluid obtained from blisters and from the 
burns during the 4-h collection periods. The amount of fluid was 
maximal between days 2 and 4, and then declined. For patient 5-4, 
the size of the wound and its position on the arm made it impossible 
to collect wound fluid quantitatively. 
In blister and burn fluid samples from patients 5-1 and 5-2, the 
protein concentration was about 30-50 mg/ml, except on day 13 
for patient 5-2 when burn fluid protein decreased to <20 mg/ml. 
Plasma protein concentrations averaged 40-65 mg/ml. Patient 
5-4, who had a more severe burn and received higher amounts of 
Figure 1. Burn wound fluid collection. Data shown are the sample 
volumes of blister (B) and burn fluid collected from the patients indicated at 
the times shown. Other details are in Materials a/ld Methods. 
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intravenous saline than the other patients, had lower protein con-
centrations in burn fluid and plasma (10-25 mg/ml and 30-
45 mg/ml) . One-dimensional polypeptide profiles of wound fluid 
and plasma (not shown) indicated that there were no major changes 
in the polypeptide profiles over the course of the collection period. 
Metalloproteinase Activation Cascade in Burn Fluid For all 
three patients, a similar pattern of gelatinase expression and activa-
tion was observed in burn-fluid samples collected during the first 
4 d after injury. Typical results for the series of samples from patient 
5-2 are shown in Fig 2, and Fig 3 presents a detailed analysis of the 
sample obtained on day 4. There was little gelatinase activity de-
tected in plasma. Also, all of the gelatinases were metalloproteinases 
because enzyme activity was inhibited by addition of o-phenanthro-
line (data not shown) . 
Burn fluid (Fig 3, lanes 3 - 5) resembled mastectomy fluid (Fig 3, 
lanes 1 and 2) in that the major gelatinase was the proenzyme form 
of MMP-9 along with its 130- and 225-kDa complexes. MMP-9 
and its complexes were identified both by gelatin zymography and 
by immunoblotting with monoclonal antibody 7-11C (Fig 3, lanes 
2 and 4). Monoclonal antibody 7-11 C detects only the proenzyme 
form of MMP-9 [16]. In addition to the proenzyme species, burn 
fluid also contained w hat appeared to be activated MMP-9. Identifi-
cation of activated MMP-9 was confirmed using monoclonal anti-
body 6-6B known to recognize both proenzyme and active enzyme 
species (Fig 3, lane 5) [16]. In other studies, we found that treatment 
of burn fluid with 1 mM p-aminophenylmercuric acetate for 4 h at 
37°C resulted in conversion of the proMMP-9 zymography band to 
MMP-9 (data not shown). Several bands recognized by monoclonal 
antibody 6-6B but not detected by zymography may correspond to 
complexes containing activated MMP-9 and tissue inhibitor of me-
talloproteinase (TIMP). 
Figure 2 shows that none of the metalloproteinases were detect-
able in blister fluid . MMP-9 proenzyme and the 225-kDa MMP-9 
complex were first observed in burn fluid on day O. Much higher 
levels of proMMP-9 as well as its activated f01"m were detected in 
burn fluid by day 2. Figure 2 also shows that several additional 
gelatinases were observed in day 2 wound fluid. One had the same 
mobility as proMMP-2; others were - 45 kDa and - 178 kDa. In 
Figure 2. Appearance of gelatinases in blister and burn fluid. Samples 
(60/lg) from patient 5-2 of blister fluid (B) and burn fluid collected at the 
times indicated were subjected to gelatin zymography. Mastectomy fluid 
(MF, 60 /lg) was run as a control. Other details are in Materials alld Methods. 
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Figure 3. Comparison of burn fluid by gelatin zymography and 
immunoblotting with antibodies against MMP-9. Samples of mastec-
tomy fluid (Iall es 1 alld 2) and burn fluid (Iall es 3 -5) (patient 5-2, day 4) were 
subjected to gelatin zymography (Iatles 1 alld 3) or Immunoblottcd wIth 
antibodies against MMP-9 proenzyme (Iall es 2 alld 4) or MMP-9 (Iall e 5). 
Sample sizcs wcre as follows: lanes 1 alld 3,60 Jlg; lalle 2, 100 Jlg; lalles 4 alld 5, 
75 Jlg. Samples for SDS-PAGE werc preparcd in non-reducing sample 
buffer. Othcr details are in Materials alld Methods. 
day 4 wound fluid, the levels of these components had increased, 
and activated forms of MMP-2 and the - 45 kDa component were 
evident. In general, MMP-2 and - 45 kDa component occurred at 
much lower levels than MMP-9 and were not always detectable on 
the zymograms. 
The above results were quantified by scanning densitometric data 
and the data shown in Fig 4 confirm that the highest levels of 
metalloproteinases occurred on day 4. Subsequently, the level of 
activated MMP-9 declined as did the MMP-9 complexes (225 kDa 
and 130 kDa) and a 178-kDa gelatinase. Therefore, burn-fluid me-
talloproteinases showed a highly specific pattern of expression and 
activation. 
Similar patterns of metalloproteinase appearance and expression 
were observed for all three patients during the first 4 d after injury. 
Subsequently, however, the patterns were quite different. Figure 5 
shows that unlike the decrease in activated MMP-9 observed for 
patient 5-2 between day 4 and day 8 (see also Fig 2), the levels of 
activated MMP-9 increased between day 4 and day 8 for patient 5-1 
and between day 4 and day 6 for patient 5-4. 
Figure 6 shows MM-9/proMMP-9 ratios based on densitome-
tric analysis. It can be seen that in the non-epithelizing burn wounds 
(5-1 and 5-4), activated metalloproteinase levels continued to in-
crease, whereas activated metalloproteinase levels declined in the 
epithelizing burn wound (5-2). As will be shown below, there also 
was considerable variability between the three patients in the occur-
rence of azocoll degradation activity and stromelysin. 
Appearance of Azocoll Degradation Activity in Burn Fluid 
In addition to analyzing proteinase profiles by zymographic analy-
sis, fluid-phase proteinase activity was determined by measuring 
azocoll degradation. Figure 7 shows that the highest level of azo-
coli degradation activity occurred on day 4 in burn fluid from pa-
tient 5-2 and on day 8 in burn fluid from patient 5-1. Burn fluid 
samples from patient 5-4 had azocoll-degrading activity detectable 
only on day 6, and the level was lower than that observed for patient 
5-1 or 5-2. Because there was a lack of correspondence between the 
pattern of gelatinase expression and activation (Figs 2 - 5) and 
fluid-phase proteinase activity (Fig 7), it seemed unlikely that gela-
tinases were responsible for azocoll degradation. Nevertheless, 
Table II shows that the azocoll-degrading enzyme was a metallo-
proteinase because enzyme activity could be blocked by o-phen-
anthroline but not by the general serine proteinase inhibitor amin-
oethylbenzenesulfonylfluoride (AEBSF) . 
THE JOURNAL OF INVESTIG ATIVE DERMATOLOGY 
800....--------iIII:::'--------, ~~~J:25k~ 1 
MF B 0 2 4 6 8 10 13 
178 
100 
50 
150~ 
o • 
MF 
k~ __ ~~~ 
B o 2 4 6 8 10 13 
500~--------------------------_, 400 ~ 130 300 
200 
100 
o , 
MF 
kDa 
B o 
I 
2 
: : :: I 
6 8 10 13 
~~ l:MP~1 
MF B 0 2 4 6 8 10 13 
Day of Burn 
Figure 4. Quantitative analysis of gelatinase profiles. The results 
shown in Fig 2 were analyzed by scanning densitometry. Data shown arc for 
MMP-9 proenzyme and its 130- and 225-kDa complexes, for activated 
MMP-9, and for the unidentified 178-kDa gclatinase. Other details are in 
Materials arId Met.lJOds. 
Appearance of Stromelysin in Burn Fluid The metallopro-
teinase stromelysin (MMP-3) also can degrade azocoll , and Fig 8 
shows an immunoblotting analysis of stromelysin in blister and 
burn fluid . Samples of stromelysin proenzyme (S) and activated 
stromelysin (*S) were used as controls. Stromelysin appeared in the 
burn fluid of patients 5-1 and 5-2 beginning on day 4. Patient 5-1 
showed only the activated form of stomelysin, which increased 
from day 4 to day 8. In marked contrast, samples from patient 5-2 
contained a mixture of strome lysin pro- and activated-enzyme spe-
cies, with the highest level of activated enzyme on day 4. No stro-
melysin was detected in burn-fluid samples from patient 5-4. These 
results indicated a general correlation between stromelysin expres-
sion and azocoll activity (Fig 7). 
DISCUSSION 
In this paper, we present a longitudinal study on the human wound 
environment following burn injury. The patients who participated 
in this study had burns involving their upper extremities, and the 
fluid composition of the wound environment was analyzed in sam-
ples of wound fluid obtained from patient blisters and from the 
wound site. The pattern of fluid accumulation was consistent with 
the pattern of perfusion in burn wounds: edema combined with 
local stasis, followed by edema combined with locally restored 
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Figure S. Comparison of gelatinase profiles between days 4 and 8. 
Samples of burn fluid (60 Jig) from patient 5-1 (days 4, 6, and 8), patient 5-2 
(days 4, 6, 8), and patient 5-4 (days 4 and 6) were subjected to gelatin 
zymography. Other details are in Materials alld Methods. 
blood flow, followed by decreasing edema. In general, the overall 
polypeptide profile of wound fluid was essentially the same as in 
plasma although the total protein concentration was reduced by 
-25%. 
Beginning on day 0, MMP-9 proenzyme and the 225-kDa 
MMP-9 complex were detected in burn fluid. The appearance of 
MMP-9 in burn fluid samples beginning 4-8 h after injury is con-
sistent with neutrophils as the initial source of this enzyme [19,20]. 
MMP-9 released by neutrophils may playa role in cell migration 
and remodeling of denatured collagen. Further accumulation as 
well as activation of MMP-9 occurred between day 0 and day 2. 
These findings are consistent with our previous studies on single 
samples of burn fluid from different patie~ts in which we detected 
markedly increased levels of metalloprotelllases on day 2 compared 
to day 1 after burn wound injury [5] . . 
Although much is known about the structure and function of 
MMP-9, little is known about its biologic activation [10,21]. In vitro 
experiments have implicated plasmin in the activation cascade for 
stromelysin (MMP-3) and interstitial collagenase (MMP-1) [22), 
but plasmin reportedly cannot activate MMP-9 [23] . Recently, It 
was shown that MMP-3 can activate MMP-9 ill Il itro [24], but 
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Figure 6. Quantitative analysis of the MMP-9!proMMP-9 ratio. The 
results in Fig 5 were analyzed by scanning densitometry. Data shown are the 
ratio of activated MMP-9 to MMP-9 proenzyme. Other details are in Materi-
als and Methods . 
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Figure 7. Fluid-phase proteinase activity in blister and burn fluid. 
Samples (0.4 mg) from patients 5-1, 5-2, and 5-4 of burn fluid collected at 
the times indicated were analyzed for proteinase activity using the Azocoll 
assay. Data were corrected for background by subtracting "buffer" values 
from sample va lues (sec Table II). Other details are in Materials alld Methods. 
MMP-3 was not detected in burn fluid until day 4, 2 dafter MMP-9 
activation. Moreover, wound fluid from patient 5-4 did not have 
detectable MMP-3 activity although MMP-9 was activated. There-
fore, unless a matrix-bound form of stromelysin is responsible for 
MMP-9 activation, it seems unlikely that MMP-3 functions as an in 
villa activator of MMP-9. Although activated MMP-9 was detected 
based on immunoblotting and migration on zymograms, MMP-9 
levels did not appear to correlate with fluid-phase proteinase activ-
ity measured by azocoll degradation. 
The burn fluid gelatinase profile increased in complexity up to 
day 4. The MMP-9 group of enzymes predominated, but other 
gelatinases also were detected including proenzyme and activated 
MMP-2, a 178-kDa gelatinase, and an - 45-kDa group of gelatin-
ases. A high ratio of MMP-9 to MMP-2 in burn fluid is consistent 
with previous studies on mastectomy fluid and chronic wound fluid 
where MMP-9 levels were found to be five- to tenfold higher than 
MMP-2 [4]. MMP-9 levels also were two- to fivefold higher than 
MMP-2 in human dermatosis blister fluid [25] . High MMP-9/ 
Table II. Effect of Inhibitors on Azocoll Degradation" 
Azocoll Degradation (00 520 ) 
Sample Control + -o-phcnanthroline + AEBSF 
Buffer 0.29 ± 0.07 0.35 ± 0.06 0.18 ± 0.04 
Collagenase 1.2 ± 0.06 0.33 ± 0.04 1.3 ± 0.01 
BF 5-1 (day 4) 0.40 ± 0.05 0.25 ± 0.01 0.40 ± 0.04 
BF-5-1 (day 8) 0.95 ± 0.04 0.40 ± 0.03 0.89 ± 0.13 
BF-5-2 (day 4) 0.64 ± 0.07 0.33 ± 0.04 0.46 ± 0.13 
• Samples of burn fluid were tested for azocoll degradation. 10 mM o-phenanthroline 
or 1 mM AEBSF were added as indicated. Collagenase (25 ng) (c1ostridiopeptidase A, 
Sigma Chemical Co.) was used as a control. Data shown arc average ± SD from tripli-
cate samples. Other details are in Materials and Methods. 
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Figure 8. Appearance of stroDlelysin in burn fluid. Samples (75 J-lg) 
from patients 5-1, 5-2, and 5-4 of burn fluid collected on the days indicated 
were subjected to SOS-PAGE and immunoblotted with antibodies against 
MMP-3. Samples (0.1 J-lg) of purified stromelysin (S) and activated strome-
lysin (·S) were run as controls. Samples for SDS-PAGE were prepared in 
non-reducing sample buffer. Both proenzyme and enzyme forms of str'ome-
lysin appear as doublets because of autolysis. Other details are in Materials and 
Methods. 
MMP-2 ratios probably are typical of cutaneous wounds that in-
volve the vascular inflammatory response. In marked contrast, 
higher levels of MMP-2 compared to MMP-9 were observed in 
studies on gelatinases appearing after injury to an avascular tissue, 
the rabbit cornea [26]. Wound fluid isolated from pig wounds 1-
3 d post-wounding was reported to contain about equal amounts of 
69- and 300-kDa gelatinases, but the identity of these enzymes was 
not determined [27] . 
The appearance of proenzyme MMP-2 in burn fluid by day 2 and 
its activation by day 4 indicated that stromal cells responsible for 
production of this enzyme [28] move into the burn matrix very 
rapidly. In situ hybridization studies have shown weak labeling of 
mRNAs for interstitial collagenase (MMP-1) and TIMP in human 
burn wounds as early as day 2 after injury [29] . In the rabbit corneal 
injury model, elevated MMP-2levels were detected 3 d after injury 
and MMP-2 activation occurred by day 5 [26]. In another matrix-
remodeling process, mammary involution, elevated levels ofMMP-
2 were detected on day 1 and MMP-2 activation occurred by day 3 
[30]. The similarity in timing between our findings with wound 
fluid and these other studies indicates that analysis of the human 
wound environment using wound fluid provides information simi-
lar to that obtained when wound tissue is excised and analyzed. 
Although burn-fluid samples from all three patients showed a 
similar gelatinase expression/activation sequence up to day 4, there 
were profound differences at later times. In the case of patient 5-2, 
whose wound began epithelial budding, there was a marked regres-
sion in levels of activated gelatinases after day 4. In marked contrast, 
metalloproteinase regression was not observed in samples from pa-
tients 5-1 and 5-4, whose wounds did not begin epithelial budding 
and required skin grafting. Also, stromelysin activity and Azocoll-
degrading activity were most prominent in burn fluid from the 
epithelizing wound and present at lower levels in the more serious 
wounds. Based on the limited patient sample so far, we cannot 
determine if these differences result from individual variability or if 
they reflect wound size or depth or rate of healing. The possbility 
that epithelization regulates metalloproteinase levels has been sug-
gested by recent studies on pig wounds where decreased interstitial 
collagenase (MMP-1) expression was found to correlate with 
wound epithelization [31]. 
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